Anti-diabetic action of 7-O-galloyl-D-sedoheptulose, a polyphenol from Corni Fructus, through ameliorating inflammation and inflammation-related oxidative stress in the pancreas of type 2 diabetics

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 5, 2013, Pages 723-732

  Park, Chan Hum ^a   Tanaka, Takashi ^b   Yokozawa, Takako ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

7 O galloyl D sedoheptulose; Fibrosis; Inflammation; Oxidative stress; Pancreas; Type 2 diabetes

Indexed keywords

7 O GALLOYL DEXTRO SEDOHEPTULOSE; ADIPONECTIN; ANTIDIABETIC AGENT; C PEPTIDE; CYCLOOXYGENASE 2; FIBRONECTIN; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 6; LEPTIN; RESISTIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; FLUID INTAKE; FOOD INTAKE; IMMUNOBLOTTING; LIPID PEROXIDATION; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; C-PEPTIDE; CORNUS; CYTOKINES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FIBRONECTINS; HEPTOSES; HYPOGLYCEMIC AGENTS; INSULIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; OXIDATIVE STRESS; PANCREAS; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRANSCRIPTION FACTOR AP-1;

EID: 84876943962     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00543     Document Type: Article

References (44)

1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart Association National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 109, 433-438 (2004).
2. de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett., 582, 97-105 (2008).
3. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet, 340, 925-929 (1992).
4. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183-1197 (1997).
5. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest., 104, 787-794 (1999).
6. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y. Oxidative stress is associated with adiposity and insulin resistance in men. J. Clin. Endocrinol. Metab., 88, 4673-4676 (2003).
7. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes, 52, 1-8 (2003).
8. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid. Redox Signal., 7, 1040-1052 (2005).
9. Fridlyand LE, Philipson LH. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes. Metab., 8, 136-145 (2006).
10. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 440, 944-948 (2006).
11. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahashi H. Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes, 52, 581-587 (2003).
12. Evans JL. Antioxidants: do they have a role in the treatment of insulin resistance? Indian J. Med. Res., 125, 355-372 (2007).
13. Cardozo AK, Heimberg H, Heremans Y, Leeman R, Kutlu B, Kruhøffer M, Ørntoft T, Eizirik DL. A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J. Biol. Chem., 276, 48879-48886 (2001).
14. Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol., 164, 6509-6519 (2000).
15. Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep., 26, 1001-1043 (2009).
16. Kim YJ, Kim YA, Yokozawa T. Attenuation of oxidative stress and inflammation by gravinol in high glucose-exposed renal tubular epithelial cells. Toxicology, 270, 106-111 (2010).
17. Kim YJ, Kim YA, Yokozawa T. Pycnogenol modulates apoptosis by suppressing oxidative stress and inflammation in high glucose-treated renal tubular cells. Food Chem. Toxicol., 49, 2196-2201 (2011).
18. Lee YA, Kim YJ, Cho EJ, Yokozawa T. Ameliorative effects of proanthocyanidin on oxidative stress and inflammation in streptozotocin-induced diabetic rats. J. Agric. Food Chem., 55, 9395-9400 (2007).
19. Lee YA, Cho EJ, Yokozawa T. Effects of proanthocyanidin preparations on hyperlipidemia and other biomarkers in mouse model of type 2 diabetes. J. Agric. Food Chem., 56, 7781-7789 (2008).
20. Yokozawa T, Park CH, Noh JS, Tanaka T, Cho EJ. Novel action of 7-O-galloyl-D-sedoheptulose isolated from Corni Fructus as a hypertriglyceridaemic agent. J. Pharm. Pharmacol., 61, 653-661 (2009).
21. Yamabe N, Kang KS, Park CH, Tanaka T, Yokozawa T. 7-O-Galloyl-D- sedoheptulose is a novel therapeutic agent against oxidative stress and advanced glycation endproducts in the diabetic kidney. Biol. Pharm. Bull., 32, 657-664 (2009).
22. Park CH, Noh JS, Yamabe N, Kang KS, Tanaka T, Yokozawa T. Beneficial effect of 7-O-galloyl-D-sedoheptulose on oxidative stress and hepatic and renal changes in type 2 diabetic db/db mice. Eur. J. Pharmacol., 640, 233-242 (2010).
23. Ali SF, LeBel CP, Bondy SC. Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology, 13, 637-648 (1992).
24. Naito C, Yamanaka T. [Lipid peroxides in atherosclerotic diseases (author's transl.)]. Nippon Ronen Igakkai Zasshi, 15, 187-191 (1978).
25. Portha B, Picon L, Rosselin G. Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia, 17, 371-377 (1979).
26. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem., 86, 271-278 (1978).
27. Komatsu S. Extraction of nuclear proteins. Methods Mol. Biol., 355, 73-77 (2007).
28. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 79, 727-747 (2004).
29. Crozier A, Yokota T, Jaganath IB, Marks SC, Saltmarsh M, Clifford MN. Secondary metabolites in fluits, vegetables, beverages and other plant based dietary components. Plant secondary metabolites: occurrence, structure and role in the human diet. (Crozier A, Clifford MN, Ashihara H eds.), Blackwell Publishing, Oxford, pp. 208-302 (2006).
30. Torabian S, Haddad E, Rajaram S, Banta J, Sabaté J. Acute effect of nut consumption on plasma total polyphenols, antioxidant capacity and lipid peroxidation. J. Hum. Nutr. Diet., 22, 64-71 (2009).
31. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am. J. Clin. Nutr., 81 (Suppl.), 215S-217S (2005).
32. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollman PCH, Katan MB. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med., 155, 381-386 (1995).
33. Mclarty JW. Antioxidants and cancer: the epidemiologic evidence. Antioxidants and disease prevention. (Garewal HS ed.), CRC Press, New York, pp. 45-66 (1997).
34. Albanes D, Hartman TJ. Antioxidants and cancer: evidence from human observational studies and intervention trials. Antioxidant status, diet, nutrition and health. (Papas AM ed.), CRC Press, Florida, pp. 497-544 (1999).
35. Noh JS, Park CH, Tanaka T, Yokozawa T. 7-O-Galloyl-D-sedoheptulose attenuates oxidative stress-induced diabetic injury via decreasing expression of nuclear factor-κB- and apoptosis-related protein in the liver. Biol. Pharm. Bull., 35, 950-956 (2012).
36. Park CH, Noh JS, Tanaka T, Yokozawa T. 7-O-Galloyl-D-sedoheptulose ameliorates renal damage triggered by reactive oxygen species-sensitive pathway of inflammation and apoptosis. J. Pharm. Pharmacol., 64, 1730-1740 (2012).
37. Harrod JS, Rada CC, Pierce SL, England SK, Lamping KG. Altered contribution of RhoA/Rho kinase signaling in contractile activity of myometrium in leptin receptor-deficient mice. Am. J. Physiol. Endocrinol. Metab., 301, E362-E369 (2011).
38. Las G, Shirihai OS. The role of autophagy in β-cell lipotoxicity and type 2 diabetes. Diabetes Obes. Metab., 12 (Suppl. 2), 15-19 (2010).
39. Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Matsuhisa M, Yamasaki Y. Oxidative stress and the JNK pathway in diabetes. Curr. Diabetes Rev., 1, 65-72 (2005).
40. Kumar NB, Kazi A, Smith T, Crocker T, Yu D, Reich RR, Reddy K, Hastings S, Exterman M, Balducci L, Dalton K, Bepler G. Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. Curr. Treat. Options Oncol., 11, 107-117 (2010).
41. Shan J, Fu J, Zhao Z, Kong X, Huang H, Luo L, Yin Z. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-kappaB and JNK/AP-1 activation. Int. Immunopharmacol., 9, 1042-1048 (2009).
42. Kaneto H, Matsuoka TA, Katakami N, Kawamori D, Miyatsuka T, Yoshiuchi K, Yasuda T, Sakamoto K, Yamasaki Y, Matsuhisa M. Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes. Curr. Mol. Med., 7, 674-686 (2007).
43. Guest CB, Park MJ, Johnson DR, Freund GG. The implication of proinflammatory cytokines in type 2 diabetes. Front. Biosci., 13, 5187-5194 (2008).
44. Ndisang JF. Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity. Mediators Inflamm., 2010, 359732 (2010).